• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种鼻腔纳洛酮给药装置的人体因素比较评估:NARCAN鼻腔喷雾剂和带鼻腔雾化器的纳洛酮预充式注射器

Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer.

作者信息

Tippey Kathryn G, Yovanoff Mary, McGrath Larry S, Sneeringer Peter

机构信息

Design Science Consulting, Philadelphia, PA, USA.

出版信息

Pain Ther. 2019 Jun;8(1):89-98. doi: 10.1007/s40122-019-0118-0. Epub 2019 Mar 15.

DOI:10.1007/s40122-019-0118-0
PMID:30877583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6513948/
Abstract

INTRODUCTION

Opioid overdose rescue situations are time-critical, high-stress scenarios that frequently require nonmedical first responders or bystanders to intervene and administer naloxone to avoid opioid-induced fatalities. Training nonmedical personnel to respond during such mentally constraining situations presents the human factors challenge of how best to design a safe and effective lay delivery system. This paper comparatively evaluates the ease of use of two nasal naloxone administration products: NARCAN Nasal Spray and a naloxone prefilled syringe with nasal atomizer (PFS-NA).

METHODS

We evaluated the use requirements and usability of NARCAN Nasal Spray versus a naloxone PFS-NA using a systems-oriented method. First, we determined the use requirements of different user groups. Next, we focused on constructing a human factors task analysis of both products. Finally, we conducted a comparative risk assessment of the tasks that were different between the two products.

RESULTS

Inexperienced users, such as nonmedical first responders and bystanders, are at the highest risk of incorrectly administering naloxone, particularly in high-stress emergency opioid overdose situations. The device Preparation and Medication Delivery tasks most differentiate the use of NARCAN Nasal Spray and a PFS-NA. The level of task complexity and number of steps within those tasks is substantially greater for a PFS-NA than for the NARCAN Nasal Spray.

CONCLUSIONS

NARCAN Nasal Spray requires fewer steps and is easier to administer than a naloxone PFS-NA. Thus, using NARCAN Nasal Spray should increase the likelihood that nonmedical personnel correctly deliver naloxone in time-critical, high-stress opioid overdose rescue situations.

FUNDING

ADAPT Pharma, Inc.

摘要

引言

阿片类药物过量急救情况时间紧迫、压力巨大,常常需要非医疗急救人员或旁观者进行干预并注射纳洛酮,以避免阿片类药物导致的死亡。培训非医疗人员在这种精神紧张的情况下做出反应,带来了如何设计一个安全有效的非专业给药系统这一人因工程学挑战。本文比较评估了两种鼻腔用纳洛酮给药产品的易用性:NARCAN鼻喷雾剂和配有鼻腔雾化器的纳洛酮预充式注射器(PFS-NA)。

方法

我们采用面向系统的方法评估了NARCAN鼻喷雾剂与纳洛酮PFS-NA的使用要求和可用性。首先,我们确定了不同用户群体的使用要求。接下来,我们着重构建了这两种产品的人因工程学任务分析。最后,我们对两种产品之间不同的任务进行了比较风险评估。

结果

经验不足的用户,如非医疗急救人员和旁观者,在错误注射纳洛酮方面风险最高,尤其是在高压力的阿片类药物过量紧急急救情况下。设备准备和药物给药任务最能区分NARCAN鼻喷雾剂和PFS-NA的使用。PFS-NA的任务复杂程度和这些任务中的步骤数量比NARCAN鼻喷雾剂要大得多。

结论

与纳洛酮PFS-NA相比,NARCAN鼻喷雾剂所需步骤更少,给药更容易。因此,在时间紧迫、压力巨大的阿片类药物过量急救情况下,使用NARCAN鼻喷雾剂应能增加非医疗人员正确及时注射纳洛酮的可能性。

资金来源

ADAPT制药公司

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/6513948/297f69360df8/40122_2019_118_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/6513948/3fe766686b7f/40122_2019_118_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/6513948/14d9bb71b3e7/40122_2019_118_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/6513948/1482ef1ba99f/40122_2019_118_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/6513948/ce2bd8c1d8fd/40122_2019_118_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/6513948/c21151c32b64/40122_2019_118_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/6513948/297f69360df8/40122_2019_118_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/6513948/3fe766686b7f/40122_2019_118_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/6513948/14d9bb71b3e7/40122_2019_118_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/6513948/1482ef1ba99f/40122_2019_118_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/6513948/ce2bd8c1d8fd/40122_2019_118_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/6513948/c21151c32b64/40122_2019_118_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d70/6513948/297f69360df8/40122_2019_118_Fig6_HTML.jpg

相似文献

1
Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer.两种鼻腔纳洛酮给药装置的人体因素比较评估:NARCAN鼻腔喷雾剂和带鼻腔雾化器的纳洛酮预充式注射器
Pain Ther. 2019 Jun;8(1):89-98. doi: 10.1007/s40122-019-0118-0. Epub 2019 Mar 15.
2
Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.旁观者多次使用纳洛酮治疗阿片类药物过量逆转的真实世界研究。
Harm Reduct J. 2022 May 20;19(1):49. doi: 10.1186/s12954-022-00627-3.
3
Correction to: Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer.对《两种鼻腔纳洛酮给药装置的人体因素比较评估:NARCAN鼻腔喷雾剂和带鼻腔雾化器的纳洛酮预充式注射器》的勘误
Pain Ther. 2019 Jun;8(1):99. doi: 10.1007/s40122-019-0123-3.
4
A Novel Faster-Acting, Dry Powder-Based, Naloxone Intranasal Formulation for Opioid Overdose.一种新型、起效更快的纳洛酮鼻腔干粉制剂,用于治疗阿片类药物过量。
Pharm Res. 2022 May;39(5):963-975. doi: 10.1007/s11095-022-03247-5. Epub 2022 Apr 6.
5
Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: a review.非医疗人员使用鼻内纳洛酮及相关阿片类药物过量干预策略:综述
Subst Abuse Rehabil. 2017 Oct 11;8:79-95. doi: 10.2147/SAR.S101700. eCollection 2017.
6
Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations.社区环境中4毫克纳洛酮鼻喷雾剂的使用:社区组织使用情况调查
Curr Med Res Opin. 2018 Apr;34(4):573-576. doi: 10.1080/03007995.2017.1334637. Epub 2017 Jun 7.
7
Comparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA-Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxone Device.经美国食品药品监督管理局批准的鼻腔内和肌肉内装置与常见的自制鼻腔内纳洛酮装置使用后纳洛酮药代动力学特性的比较。
J Clin Pharmacol. 2019 Aug;59(8):1078-1084. doi: 10.1002/jcph.1401. Epub 2019 Mar 12.
8
Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.一种获美国食品药品监督管理局批准用于治疗阿片类药物过量的鼻内纳洛酮产品的药代动力学特性及人体使用特征
J Clin Pharmacol. 2016 Oct;56(10):1243-53. doi: 10.1002/jcph.759. Epub 2016 Jun 10.
9
A randomized usability assessment of simulated naloxone administration by community members.社区成员模拟纳洛酮给药的随机可用性评估。
Addiction. 2018 Dec;113(12):2300-2304. doi: 10.1111/add.14416. Epub 2018 Sep 11.
10
Narcan and Narcan't: Implementation factors influencing police officer use of Narcan.纳洛酮和纳洛酮无效:影响警察使用纳洛酮的实施因素。
Soc Sci Med. 2021 Feb;270:113669. doi: 10.1016/j.socscimed.2021.113669. Epub 2021 Jan 2.

引用本文的文献

1
The Opioid Overdose Resuscitation Education for Addiction Counselors and Trainees (Opioid Overdose REACT) naloxone response education pilot project improved confidence and knowledge among addiction counselors and trainees.阿片类药物过量复苏教育计划(Opioid Overdose REACT)的纳洛酮反应教育试点项目提高了成瘾咨询师和学员的信心和知识。
Clin Toxicol (Phila). 2023 Jul;61(7):509-517. doi: 10.1080/15563650.2023.2229508. Epub 2023 Jul 10.
2
The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters.鼻子有门道:包括癫痫丛集在内的神经系统疾病鼻内给药的机遇与挑战。
Epilepsy Behav Rep. 2022 Dec 28;21:100581. doi: 10.1016/j.ebr.2022.100581. eCollection 2023.
3

本文引用的文献

1
Naloxone dosage for opioid reversal: current evidence and clinical implications.用于阿片类药物逆转的纳洛酮剂量:当前证据及临床意义
Ther Adv Drug Saf. 2018 Jan;9(1):63-88. doi: 10.1177/2042098617744161. Epub 2017 Dec 13.
2
Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 - 10 States, July-December 2016.2016年7月至12月,涉及芬太尼、芬太尼类似物和U-47700的死亡事件 - 10个州
MMWR Morb Mortal Wkly Rep. 2017 Nov 3;66(43):1197-1202. doi: 10.15585/mmwr.mm6643e1.
3
Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.
Design details for overdose education and take-home naloxone kits: Codesign with family medicine, emergency department, addictions medicine and community.过量用药教育和可携带纳洛酮套件的设计细节:与家庭医学、急诊部、成瘾医学和社区共同进行联合设计。
Health Expect. 2022 Oct;25(5):2440-2452. doi: 10.1111/hex.13559. Epub 2022 Jul 31.
4
Instillation of a Dry Powder in Nasal Casts: Parameters Influencing the Olfactory Deposition With Uni- and Bi-Directional Devices.干粉在鼻模中的滴注:单向和双向装置影响嗅觉沉积的参数。
Front Med Technol. 2022 Jun 27;4:924501. doi: 10.3389/fmedt.2022.924501. eCollection 2022.
用于海洛因、处方阿片类药物及非法制造的芬太尼过量中毒的纳洛酮:应对动态流行疫情的挑战与创新
Int J Drug Policy. 2017 Aug;46:172-179. doi: 10.1016/j.drugpo.2017.06.005. Epub 2017 Jul 4.
4
Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.用于预防海洛因及其他阿片类药物过量致死的带回家式纳洛酮二十年——构想与成熟历程
Drug Alcohol Depend. 2017 Sep 1;178:176-187. doi: 10.1016/j.drugalcdep.2017.05.001. Epub 2017 May 25.
5
Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016.2014 - 2016年马萨诸塞州芬太尼过量用药的特征
MMWR Morb Mortal Wkly Rep. 2017 Apr 14;66(14):382-386. doi: 10.15585/mmwr.mm6614a2.
6
Awareness and Attitudes Toward Intranasal Naloxone Rescue for Opioid Overdose Prevention.对用于预防阿片类药物过量的鼻内纳洛酮急救的认知与态度
J Subst Abuse Treat. 2016 Oct;69:44-9. doi: 10.1016/j.jsat.2016.07.005. Epub 2016 Jul 18.
7
Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.一种获美国食品药品监督管理局批准用于治疗阿片类药物过量的鼻内纳洛酮产品的药代动力学特性及人体使用特征
J Clin Pharmacol. 2016 Oct;56(10):1243-53. doi: 10.1002/jcph.759. Epub 2016 Jun 10.
8
American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.美国成瘾医学协会(ASAM)关于使用药物治疗阿片类药物使用成瘾的国家实践指南。
J Addict Med. 2015 Sep-Oct;9(5):358-67. doi: 10.1097/ADM.0000000000000166.
9
Comparative Usability Study of a Novel Auto-Injector and an Intranasal System for Naloxone Delivery.新型自动注射器和纳洛酮鼻内给药系统的比较可用性研究。
Pain Ther. 2015 Jun;4(1):89-105. doi: 10.1007/s40122-015-0035-9. Epub 2015 Apr 25.
10
Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.阿片类药物过量使用时纳洛酮安全性综述:新技术与扩大公众可及性的实际考量
Ther Adv Drug Saf. 2015 Feb;6(1):20-31. doi: 10.1177/2042098614564776.